Cerity Partners’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Hold
14,042
– – ﹤0.01% 3164
2026
Q1
$77.1K Buy
14,042
+417
+3% +$4.61K ﹤0.01% 3054
2025
Q4
$360K Buy
13,625
+12,494
+1,105% +$241K ﹤0.01% 2297
2025
Q3
$21.6K Sell
1,131
-410
-27% -$6.38K ﹤0.01% 2725
2025
Q2
$29.9K Buy
1,541
+397
+35% +$7.7K ﹤0.01% 2587
2025
Q1
$16.3K Buy
1,144
+227
+25% +$4.35K ﹤0.01% 2451
2024
Q4
$22.7K Hold
917
– – ﹤0.01% 2403
2024
Q3
$27.8K Buy
+917
New +$35.9K ﹤0.01% 2504

Other funds holding GUTS

Cerity Partners's GUTS Position: Q2 2026 in Review

Cerity Partners held its Fractyl Health (GUTS) position steady in Q2 2026 at 14,042 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

Cerity Partners first reported a position in GUTS in Q3 2024 and has held it in 8 quarters since. The position peaked at $360K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Cerity Partners held 14,042 shares of Fractyl Health worth $134K as of Q2 2026.
  • Cerity Partners left its Fractyl Health share count unchanged in Q2 2026.
  • Fractyl Health made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3164 holding.
  • Cerity Partners first reported a position in Fractyl Health in Q3 2024 and has held it in 8 quarters since.
  • Cerity Partners's Fractyl Health position peaked at $360K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.